WHO says risk of global Ebola spread is low, but high at national, regional levels

5 days ago 7

The head of the World Health Organization said on Wednesday the risk of global spread of the Ebola outbreak in DR Congo and Uganda is high at national, regional levels but low at the global level.

WHO Director-General Tedros Adhanom Ghebreyesus said so far 51 cases have been confirmed in Congo in the northern provinces of Ituri and North Kivu provinces in Congo, “although we know the scale of the epidemic is much larger".

He said Uganda has also told the UN health agency of two confirmed cases in Uganda’s capital, Kampala. “Beyond the confirmed cases, there are almost 600 suspected cases and 139 suspected,” he said. “We expect those numbers to keep increasing.” 

Read moreWHO declares global health emergency over Ebola outbreak in Congo and Uganda

A WHO ​Emergency Committee met ‌on Tuesday in Geneva and confirmed that the latest Ebola outbreak ‌of the rare Bundibugyo strain of ​the virus is a public health emergency of international concern but not ​a pandemic emergency, he ​said.

Tedros declared the emergency at the ​weekend, the first time a WHO chief has taken that step without first consulting experts, ⁠due to the urgency of the ⁠situation, ​he said.

To display this content from YouTube, you must enable advertisement tracking and audience measurement.

One of your browser extensions seems to be blocking the video player from loading. To watch this content, you may need to disable it on this site.

© France 24

05:34

No approved vaccines for rare strain

The WHO on Tuesday expressed concern over the “scale and speed” of the Bundibugyo outbreak in eastern Congo.

The virus spread undetected for weeks after the first known death as authorities tested for a more common type of Ebola and came up negative, health experts and aid workers said. The Bundibugyo virus has no approved medicines or vaccines.

Congo was expecting shipments from the USand Britain of an experimental vaccine for different types of Ebola, developed by researchers at Oxford, said Jean-Jacques Muyembe, a virus expert at the National Institute of Biomedical Research.

“We will administer the vaccine and see who develops the disease,” he said. But experts said such efforts would take time.

Ebola is a highly contagious virus and can be contracted via bodily fluids such as vomit, blood or semen. The disease it causes is rare but severe and often fatal. Symptoms include fever, headache, muscle pain, weakness, diarrhea, vomiting, stomach pain and unexplained bleeding or bruising.

During an outbreak more than a decade ago that killed more than 11,000 people, many were infected while washing bodies for funerals.

(FRANCE 24 with AFP, AP and Reuters)

Read Entire Article






<